Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
20.76
+1.32 (6.79%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Cidara Therapeutics Market Cap
Cidara Therapeutics has a market cap or net worth of $227.39 million as of April 21, 2025. Its market cap has increased by 132.75% in one year.
Market Cap
227.39M
Enterprise Value
40.32M
1-Year Change
132.75%
Ranking
Category
Stock Price
$20.76
Market Cap Chart
Since April 15, 2015, Cidara Therapeutics's market cap has increased from $203.10M to $227.39M, an increase of 11.96%. That is a compound annual growth rate of 1.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2025 | 226.60M | 19.64% |
| Dec 31, 2024 | 189.40M | 163.79% |
| Dec 29, 2023 | 71.80M | 32.47% |
| Dec 30, 2022 | 54.20M | -36.01% |
| Dec 31, 2021 | 84.70M | -3.64% |
| Dec 31, 2020 | 87.90M | -30.73% |
| Dec 31, 2019 | 126.90M | 94.63% |
| Dec 31, 2018 | 65.20M | -52.62% |
| Dec 29, 2017 | 137.60M | -20.65% |
| Dec 30, 2016 | 173.40M | -26.34% |
| Dec 31, 2015 | 235.40M | 15.90% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |